2025 Oncology Update Conference presented by HPOP
Learn How to Claim Your Credit
The 2025 Oncology Update Conference is a comprehensive, multi-disciplinary gathering designed to provide oncology professionals with the latest evidence-based updates across a wide range of cancer care topics. The program will feature expert-led sessions highlighting advancements in cancer screening, diagnostics, treatment strategies, and supportive care, with a focus on improving patient outcomes.
Event Page
Accreditation Information | 5.50
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Amedco LLC designates this activity for a maximum of 5.50 ANCC contact hours.
-
Amedco LLC designates this live activity for a maximum of 5.50 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
-
Amedco LLC designates this activity for a maximum of 5.50 knowledge-based CPE contact hours. JA4008163-9999-25-197-L01-P | JA4008163-9999-25-197-L01-T
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prio
-
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be
attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education
credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine
course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by
Amedco LLC and Total Health Conferences. Amedco LLC is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council
for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to
provide continuing education for the healthcare team.
Professions in scope for this activity are listed below.
Amedco Joint Accreditation Provider Number: 4008163
Physicians
Amedco LLC designates this live activity for a maximum of 5.50 AMA PRA Category 1 CreditsTM for physicians.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists & Pharmacy Technicians
Amedco LLC designates this activity for a maximum of 5.50 knowledge-based CPE contact hours.
JA4008163-9999-25-251-L01-P | JA4008163-9999-25-251-L01-T
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request
your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
Credits are generally reported during the first week of each month for those who claimed during the month prior.
Nurses
Amedco LLC designates this activity for a maximum of 5.50 ANCC contact hours.
Learner Notification
Objectives - After Attending This Program You Should Be Able To
1. Evaluate recent evidence-based advancements in cancer screening and diagnostics to enhance early detection and
precision in oncology care.
2. Integrate emerging therapeutic strategies across multiple tumor types into clinical practice to optimize treatment
planning and improve patient outcomes.
3. Apply updated approaches in supportive care to better manage treatment-related toxicities and improve quality of life
for oncology patients.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that
each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a
conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
Name Commercial Interest:Relationship
Christina Aquilante NA
Beth Dessner NA
Pam Gale NA
Ashley Imburgia NA
Arthur Liu NA
Spyridon Mastroyannis NA
Mackenzie Matthews NA
Christopher Merlan NA
Breanna Roscow Myriad Genetics:Employee
Myriad Genetics:Public Stock Shareholder
Leslie Ross NA
Erin Schwab INCYTE, Natera:Speakers Bureau
Anthony Sheetz NA
Reyna Wilhelm NA
Justin Kaiser NA
How to Get Your Certificate
1. Go to thc.cmecertificateonline.com
2. Click on the 2025 Oncology Update Conference presented by High Plains Oncology Professionals-HPOP
link.
3. Evaluate the meeting.
4. Print, download, or save your certificate for your records.
5. If you lose your certificate, or need help, go to help.cmecertificateonline.com
How to Get Your Certificate
Go to thc.cmecertificateonline.com
Evaluate the meeting.
Print, download, or save your certificate for your records.
If you lose your certificate, or need help, go to help.cmecertificateonline.com